|
Jul 29
|
Merck Stock Falls After Layoff Announcement, Gardasil Sales Drop
|
|
Jul 17
|
Verona Pharma (VRNA) Jumps 125% YTD; Merck $10-Billion Acquisition Bolsters Sentiment
|
|
Jul 15
|
Verona Pharma plc (VRNA) Is Unlikely To Face Antitrust Action For Merck Deal, Says Jim Cramer
|
|
Jul 15
|
What Makes Verona Pharma PLC American Depositary Share (VRNA) a Strong Momentum Stock: Buy Now?
|
|
Jul 15
|
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading
|
|
Jul 15
|
Verona Pharma plc (VRNA): A Bull Case Theory
|
|
Jul 14
|
Biotech Stocks Are Ready to Rebound. Gilead Sciences and 2 More to Watch Now.
|
|
Jul 13
|
Trump Says 200% Pharma Tariffs Are Coming. Wall Street Shrugs.
|
|
Jul 1
|
Biogen Begins Phase III Felzartamab Study for Third Kidney Disease
|
|
Jul 1
|
Here's Why Momentum in Verona Pharma (VRNA) Should Keep going
|
|
Jun 24
|
Verona Pharma price target raised to $160 from $76 at Piper Sandler
|
|
Jun 24
|
Up 515%, Watch This Biopharma Breakout
|
|
Jun 13
|
Jefferies Backs Verona Pharma plc (VRNA) After Strong Ohtuvayre Launch
|
|
May 21
|
Verona Pharma Announces June 2025 Investor Conference Participation
|
|
May 8
|
What Makes Verona Pharma plc (VRNA) a Good Investment?
|
|
May 6
|
IBD Stock Of The Day Verona Pharma Tests Buy Point After Earnings Breakout
|
|
May 6
|
Verona Pharma to Present Seven Analyses of the Phase 3 ENHANCE Studies in COPD at ATS 2025
|
|
Apr 17
|
Ritedose to double single-vial packaging capabilities with seventh Syntegon line
|
|
Apr 15
|
Verona Pharma to Report First Quarter 2025 Financial Results and Provide Corporate Update
|
|
Mar 14
|
Is Verona Pharma plc (VRNA) the Best Performing Growth Stock in 2025?
|